Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4796-4807

  Hsu, Chia Wei ^a   Yu, Jau Song ^a,b   Peng, Pei Hua ^b   Liu, Shu Chen ^b   Chang, Yu Sun ^b   Chang, Kai Ping ^b,c   Wu, Chih Ching ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

biomarker; oral cavity squamous cell carcinoma; primary cell; saliva; secretome; thrombospondin 2

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA1; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COLLAGEN TYPE 4; COMPLEMENT C 1S SUBCOMPONENT; DICKKOPF RELATED PROTEIN 1; DNAJ HOMOLOGUE SUBFAMILY B MEMBER 11; FIBRONECTIN; GOLGI MEMBRANE PROTEIN; LUMICAN; LYSYL OXIDASE HOMOLOGUE 2; PLASTIN 2; RAS RELATED PROTEIN RAP 1B; SPLICING FACTOR ARGININE SERINE RICH 3; THROMBOPLASTIN; THROMBOSPONDIN 2; TUMOR MARKER; UBIQUITIN FUSION DEGRADATION PROTEIN 1 HOMOLOGUE; UNCLASSIFIED DRUG; VASCULOTROPIN C; THROMBOSPONDIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PERINEURAL INVASION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMARY CELL CULTURE; SALIVA; SALIVA LEVEL; TANDEM MASS SPECTROMETRY; TUMOR MICROENVIRONMENT; BIOLOGY; CARCINOMA, SQUAMOUS CELL; IMMUNOASSAY; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; NONPARAMETRIC TEST; PROCEDURES; PROTEOMICS; SECRETION (PROCESS); TAIWAN; TUMOR CELL CULTURE;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROTEOMICS; SALIVA; STATISTICS, NONPARAMETRIC; TAIWAN; TANDEM MASS SPECTROMETRY; THROMBOSPONDINS; TUMOR CELLS, CULTURED;

EID: 84908880904     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500038k     Document Type: Article

References (66)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013 CA Cancer J. Clin. 2013, 63 (1) 11-30
2. Mashberg, A. Comment on Head and neck cancer N. Engl. J. Med. 1993, 328 (24) 1783
3. Author reply 1784.
4. Chen, Y. J.; Chang, J. T.; Liao, C. T.; Wang, H. M.; Yen, T. C.; Chiu, C. C.; Lu, Y. C.; Li, H. F.; Cheng, A. J. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis Cancer Sci. 2008, 99 (8) 1507-14
5. Mashberg, A. Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration Oral Oncol. 2000, 36 (3) 253-5
6. Kulasingam, V.; Diamandis, E. P. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies Nat. Clin. Pract. Oncol. 2008, 5 (10) 588-99
7. Lin, Q.; Tan, H. T.; Lim, H. S.; Chung, M. C. Sieving through the cancer secretome Biochim. Biophys. Acta 2013, 1834 (11) 2360-71
8. Pavlou, M. P.; Diamandis, E. P. The cancer cell secretome: a good source for discovering biomarkers? J. Proteomics 2010, 73 (10) 1896-906
9. Wu, C. C.; Hsu, C. W.; Chen, C. D.; Yu, C. J.; Chang, K. P.; Tai, D. I.; Liu, H. P.; Su, W. H.; Chang, Y. S.; Yu, J. S. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas Mol. Cell. Proteomics 2010, 9 (6) 1100-17
10. Loei, H.; Tan, H. T.; Lim, T. K.; Lim, K. H.; So, J. B.; Yeoh, K. G.; Chung, M. C. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer J. Proteome Res. 2012, 11 (3) 1759-72
11. Planque, C.; Kulasingam, V.; Smith, C. R.; Reckamp, K.; Goodglick, L.; Diamandis, E. P. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol. Cell. Proteomics 2009, 8 (12) 2746-58
12. Wang, C. L.; Wang, C. I.; Liao, P. C.; Chen, C. D.; Liang, Y.; Chuang, W. Y.; Tsai, Y. H.; Chen, H. C.; Chang, Y. S.; Yu, J. S.; Wu, C. C.; Yu, C. J. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome J. Proteome Res. 2009, 8 (10) 4428-40
13. Faca, V. M.; Ventura, A. P.; Fitzgibbon, M. P.; Pereira-Faca, S. R.; Pitteri, S. J.; Green, A. E.; Ireton, R. C.; Zhang, Q.; Wang, H.; OBriant, K. C.; Drescher, C. W.; Schummer, M.; McIntosh, M. W.; Knudsen, B. S.; Hanash, S. M. Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains PLoS One 2008, 3 (6) e2425
14. Gunawardana, C. G.; Kuk, C.; Smith, C. R.; Batruch, I.; Soosaipillai, A.; Diamandis, E. P. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer J. Proteome Res. 2009, 8 (10) 4705-13
15. Bernhard, O. K.; Greening, D. W.; Barnes, T. W.; Ji, H.; Simpson, R. J. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma Biochim. Biophys. Acta 2013, 1834 (11) 2372-9
16. Wu, C. C.; Chen, H. C.; Chen, S. J.; Liu, H. P.; Hsieh, Y. Y.; Yu, C. J.; Tang, R.; Hsieh, L. L.; Yu, J. S.; Chang, Y. S. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes Proteomics 2008, 8 (2) 316-32
17. Pavlou, M. P.; Dimitromanolakis, A.; Diamandis, E. P. Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer Proteomics 2013, 13 (7) 1083-95
18. Chang, Y. T.; Wu, C. C.; Shyr, Y. M.; Chen, T. C.; Hwang, T. L.; Yeh, T. S.; Chang, K. P.; Liu, H. P.; Liu, Y. L.; Tsai, M. H.; Chang, Y. S.; Yu, J. S. Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection PLoS One 2011, 6 (5) e20029
19. Chang, K. P.; Wu, C. C.; Chen, H. C.; Chen, S. J.; Peng, P. H.; Tsang, N. M.; Lee, L. Y.; Liu, S. C.; Liang, Y.; Lee, Y. S.; Hao, S. P.; Chang, Y. S.; Yu, J. S. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis Proteomics 2010, 10 (14) 2644-60
20. Sepiashvili, L.; Hui, A.; Ignatchenko, V.; Shi, W.; Su, S.; Xu, W.; Huang, S. H.; OSullivan, B.; Waldron, J.; Irish, J. C.; Perez-Ordonez, B.; Liu, F. F.; Kislinger, T. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy Mol. Cell. Proteomics 2012, 11 (11) 1404-15
21. Yu, C. J.; Chang, K. P.; Chang, Y. J.; Hsu, C. W.; Liang, Y.; Yu, J. S.; Chi, L. M.; Chang, Y. S.; Wu, C. C. Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis J. Proteome Res. 2011, 10 (8) 3778-88
22. Pan, C.; Kumar, C.; Bohl, S.; Klingmueller, U.; Mann, M. Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions Mol. Cell. Proteomics 2009, 8 (3) 443-50
23. Sandberg, R.; Ernberg, I. The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles Genome Biol. 2005, 6 (8) R65
24. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-92
25. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-58
26. Huang da, W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2009, 4 (1) 44-57
27. Huang da, W.; Sherman, B. T.; Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists Nucleic Acids Res. 2009, 37 (1) 1-13
28. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol. 2004, 340 (4) 783-95
29. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel. 2004, 17 (4) 349-56
30. Sonnhammer, E. L.; von Heijne, G.; Krogh, A. A hidden Markov model for predicting transmembrane helices in protein sequences Proc. Int. Conf. Intell. Syst. Mol. Biol. 1998, 6, 175-82
31. Chang, K. P.; Chang, Y. T.; Liao, C. T.; Yen, T. C.; Chen, I. H.; Chang, Y. L.; Liu, Y. L.; Chang, Y. S.; Yu, J. S.; Wu, C. C. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling Clin. Chim. Acta 2011, 412 (11-12) 980-7
32. Liu, H.; Sadygov, R. G.; Yates, J. R., 3rd A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76 (14) 4193-201
33. Ginos, M. A.; Page, G. P.; Michalowicz, B. S.; Patel, K. J.; Volker, S. E.; Pambuccian, S. E.; Ondrey, F. G.; Adams, G. L.; Gaffney, P. M. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck Cancer Res. 2004, 64 (1) 55-63
34. Peng, C. H.; Liao, C. T.; Peng, S. C.; Chen, Y. J.; Cheng, A. J.; Juang, J. L.; Tsai, C. Y.; Chen, T. C.; Chuang, Y. J.; Tang, C. Y.; Hsieh, W. P.; Yen, T. C. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma PLoS One 2011, 6 (8) e23452
35. Estilo, C. L.; O-charoenrat, P.; Talbot, S.; Socci, N. D.; Carlson, D. L.; Ghossein, R.; Williams, T.; Yonekawa, Y.; Ramanathan, Y.; Boyle, J. O.; Kraus, D. H.; Patel, S.; Shaha, A. R.; Wong, R. J.; Huryn, J. M.; Shah, J. P.; Singh, B. Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis BMC Cancer 2009, 9, 11
36. Pyeon, D.; Newton, M. A.; Lambert, P. F.; den Boon, J. A.; Sengupta, S.; Marsit, C. J.; Woodworth, C. D.; Connor, J. P.; Haugen, T. H.; Smith, E. M.; Kelsey, K. T.; Turek, L. P.; Ahlquist, P. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers Cancer Res. 2007, 67 (10) 4605-19
37. Talbot, S. G.; Estilo, C.; Maghami, E.; Sarkaria, I. S.; Pham, D. K.; P, O. c.; Socci, N. D.; Ngai, I.; Carlson, D.; Ghossein, R.; Viale, A.; Park, B. J.; Rusch, V. W.; Singh, B. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung Cancer Res. 2005, 65 (8) 3063-71
38. Ye, H.; Yu, T.; Temam, S.; Ziober, B. L.; Wang, J.; Schwartz, J. L.; Mao, L.; Wong, D. T.; Zhou, X. Transcriptomic dissection of tongue squamous cell carcinoma BMC Genomics 2008, 9, 69
39. Ogoshi, K.; Kasamatsu, A.; Iyoda, M.; Sakuma, K.; Yamatoji, M.; Sakamoto, Y.; Ogawara, K.; Shiiba, M.; Tanzawa, H.; Uzawa, K. Dickkopf-1 in human oral cancer Int. J. Oncol. 2011, 39 (2) 329-36
40. Shinohara, M.; Nakamura, S.; Harada, T.; Shimada, M.; Oka, M. Mode of tumor invasion in oral squamous cell carcinoma: improved grading based on immunohistochemical examination of extracellular matrices Head Neck 1996, 18 (2) 153-9
41. Sugiura, T.; Inoue, Y.; Matsuki, R.; Ishii, K.; Takahashi, M.; Abe, M.; Shirasuna, K. VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker Int. J. Oncol. 2009, 34 (3) 673-80
42. Yapijakis, C.; Bramos, A.; Nixon, A. M.; Ragos, V.; Vairaktaris, E. The interplay between hemostasis and malignancy: the oral cancer paradigm Anticancer Res. 2012, 32 (5) 1791-800
43. Mitra, R. S.; Zhang, Z.; Henson, B. S.; Kurnit, D. M.; Carey, T. E.; DSilva, N. J. Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form Oncogene 2003, 22 (40) 6243-56
44. Weng, L. P.; Wu, C. C.; Hsu, B. L.; Chi, L. M.; Liang, Y.; Tseng, C. P.; Hsieh, L. L.; Yu, J. S. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility J. Proteome Res. 2008, 7 (9) 3765-75
45. Moenner, M.; Pluquet, O.; Bouchecareilh, M.; Chevet, E. Integrated endoplasmic reticulum stress responses in cancer Cancer Res. 2007, 67 (22) 10631-4
46. Tsai, Y. C.; Weissman, A. M. The unfolded protein response, degradation from endoplasmic reticulum and cancer Genes Cancer 2010, 1 (7) 764-778
47. Lin, C. Y.; Chen, W. H.; Liao, C. T.; Chen, I. H.; Chiu, C. C.; Wang, H. M.; Yen, T. C.; Lee, L. Y.; Chang, J. T.; Cheng, A. J. Positive association of glucose-regulated protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions Head Neck 2010, 32 (8) 1028-39
48. Ballar, P.; Pabuccuoglu, A.; Kose, F. A. Different p97/VCP complexes function in retrotranslocation step of mammalian ER-associated degradation (ERAD) Int. J. Biochem. Cell Biol. 2011, 43 (4) 613-21
49. Guo, F.; Snapp, E. L. ERdj3 regulates BiP occupancy in living cells J. Cell Sci. 2013, 126 (Pt 6) 1429-39
50. Kamb, A. Whats wrong with our cancer models? Nat. Rev. Drug Discovery 2005, 4 (2) 161-5
51. Masters, J. R. Human cancer cell lines: fact and fantasy Nat. Rev. Mol. Cell Biol. 2000, 1 (3) 233-6
52. Hu, S.; Arellano, M.; Boontheung, P.; Wang, J.; Zhou, H.; Jiang, J.; Elashoff, D.; Wei, R.; Loo, J. A.; Wong, D. T. Salivary proteomics for oral cancer biomarker discovery Clin. Cancer. Res. 2008, 14 (19) 6246-52
53. Nagler, R.; Bahar, G.; Shpitzer, T.; Feinmesser, R. Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer Clin. Cancer. Res. 2006, 12 (13) 3979-84
54. Elashoff, D.; Zhou, H.; Reiss, J.; Wang, J.; Xiao, H.; Henson, B.; Hu, S.; Arellano, M.; Sinha, U.; Le, A.; Messadi, D.; Wang, M.; Nabili, V.; Lingen, M.; Morris, D.; Randolph, T.; Feng, Z.; Akin, D.; Kastratovic, D. A.; Chia, D.; Abemayor, E.; Wong, D. T. Prevalidation of salivary biomarkers for oral cancer detection Cancer Epidemiol. Biomarkers Prev. 2012, 21 (4) 664-72
55. Makawita, S.; Diamandis, E. P. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification Clin. Chem. 2010, 56 (2) 212-22
56. Chen, Y. T.; Chen, H. W.; Domanski, D.; Smith, D. S.; Liang, K. H.; Wu, C. C.; Chen, C. L.; Chung, T.; Chen, M. C.; Chang, Y. S.; Parker, C. E.; Borchers, C. H.; Yu, J. S. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers J. Proteomics 2012, 75 (12) 3529-45
57. Krady, M. M.; Zeng, J.; Yu, J.; MacLauchlan, S.; Skokos, E. A.; Tian, W.; Bornstein, P.; Sessa, W. C.; Kyriakides, T. R. Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis Am. J. Pathol. 2008, 173 (3) 879-91
58. Matos, A. R.; Coutinho-Camillo, C. M.; Thuler, L. C.; Fonseca, F. P.; Soares, F. A.; Silva, E. A.; Gimba, E. R. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia Exp. Mol. Pathol. 2013, 94 (3) 438-44
59. Chijiwa, T.; Abe, Y.; Inoue, Y.; Matsumoto, H.; Kawai, K.; Matsuyama, M.; Miyazaki, N.; Inoue, H.; Mukai, M.; Ueyama, Y.; Nakamura, M. Cancerous, but not stromal, thrombospondin-2 contributes prognosis in pulmonary adenocarcinoma Oncol. Rep. 2009, 22 (2) 279-83
60. Kodama, J.; Hashimoto, I.; Seki, N.; Hongo, A.; Yoshinouchi, M.; Okuda, H.; Kudo, T. Thrombospondin-1 and-2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis Clin. Cancer. Res. 2001, 7 (9) 2826-31
61. MacLauchlan, S.; Yu, J.; Parrish, M.; Asoulin, T. A.; Schleicher, M.; Krady, M. M.; Zeng, J.; Huang, P. L.; Sessa, W. C.; Kyriakides, T. R. Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2 Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (46) E1137-45
62. Oshika, Y.; Masuda, K.; Tokunaga, T.; Hatanaka, H.; Kamiya, T.; Abe, Y.; Ozeki, Y.; Kijima, H.; Yamazaki, H.; Tamaoki, N.; Ueyama, Y.; Nakamura, M. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer Clin. Cancer. Res. 1998, 4 (7) 1785-8
63. Santin, A. D.; Zhan, F.; Bellone, S.; Palmieri, M.; Cane, S.; Bignotti, E.; Anfossi, S.; Gokden, M.; Dunn, D.; Roman, J. J.; OBrien, T. J.; Tian, E.; Cannon, M. J.; Shaughnessy, J., Jr.; Pecorelli, S. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy Int. J. Cancer 2004, 112 (1) 14-25
64. Rendtlew Danielsen, J. M.; Knudsen, L. M.; Dahl, I. M.; Lodahl, M.; Rasmussen, T. Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma Br. J. Hamaetol. 2007, 138 (6) 756-60
65. Horst, D.; Budczies, J.; Brabletz, T.; Kirchner, T.; Hlubek, F. Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer Cancer 2009, 115 (21) 4946-58
66. Reis, P. P.; Waldron, L.; Perez-Ordonez, B.; Pintilie, M.; Galloni, N. N.; Xuan, Y.; Cervigne, N. K.; Warner, G. C.; Makitie, A. A.; Simpson, C.; Goldstein, D.; Brown, D.; Gilbert, R.; Gullane, P.; Irish, J.; Jurisica, I.; Kamel-Reid, S. A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence BMC Cancer 2011, 11, 437